Sera from four groups of patients with different serologic markers of HBV infection were examined for HBV DNA using molecular hybridization technique and for IgM class anti-HBc using an ELISA based on the antibody capture principle. Results of HBV DNA assay were generally in good agreement with the
High levels of serum hepatitis B virus DNA in patients with ‘anti-HBc alone’: role of HBsAg mutants
✍ Scribed by O. Launay; J. Masurel; A. Servant-Delmas; A.-L. Basse-Guérineau; J.-F. Méritet; S. Laperche; P. Sogni; A. R. Rosenberg
- Book ID
- 108886624
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 155 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ؍ 60
## Abstract Continuing hepatitis B virus (HBV) infection is normally associated with the presence of hepatitis B surface antigen (HBsAg) in the serum. In spite of sensitive screening assays for HBsAg, rare cases of post‐transfusion HBV infection are still observed. Antibody to hepatitis B core anti
Sera from 79 patients with acute self-limiting hepatitis, 17 patients with acute hepatitis B evolving into chronic HBsAg carriership, and 43 chronic HBsAg carriers without a history of acute hepatitis were analyzed for presence of hepatitis B virus (HBV)-DNA by a molecular hybridization technique. I